WallStSmart
KMDA

Kamada

NASDAQ: KMDA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$8.03
-1.60% today

Updated 2026-06-03

Market cap
$414.54M
P/E ratio
20.49
P/S ratio
2.28x
EPS (TTM)
$0.35
Dividend yield
3.49%
52W range
$6 – $9
Volume
0.1M

Kamada (KMDA) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$13.44M$15.21M$14.98M$36.27M$55.92M$72.67M$70.62M$71.92M$70.11M$77.49M$102.83M$114.47M$127.19M$133.25M$103.64M$129.34M$142.52M$160.95M$180.46M
Revenue growth (YoY)+13.2%-1.5%+142.2%+54.2%+30.0%-2.8%+1.8%-2.5%+10.5%+32.7%+11.3%+11.1%+4.8%-22.2%+24.8%+10.2%+12.9%+12.1%
Cost of revenue$10.28M$15.14M$15.83M$30.20M$40.20M$49.98M$44.22M$56.31M$54.11M$55.84M$70.74M$73.00M$77.45M$85.69M$73.31M$82.64M$87.03M$90.99M$104.05M
Gross profit$3.16M$70832.00$-847151.00$6.07M$15.72M$22.69M$26.41M$15.62M$16.00M$21.65M$32.09M$41.47M$49.74M$47.55M$30.33M$46.70M$55.49M$69.97M$76.41M
Gross margin23.5%0.5%-5.7%16.7%28.1%31.2%37.4%21.7%22.8%27.9%31.2%36.2%39.1%35.7%29.3%36.1%38.9%43.5%42.3%
R&D$12.37M$9.76M$11.03M$11.82M$12.74M$16.03M$16.53M$16.25M$11.97M$9.75M$13.06M$13.61M$11.36M$13.17M$13.93M$15.19M$12.99M
SG&A$16.63M$4.11M$13.83M$4.78M$4.82M$4.41M$7.86M$7.59M$7.04M$7.64M$8.27M$8.53M$8.48M$10.14M$13.69M$15.88M$18.25M$20.41M$24.11M
Operating income$-16.32M$-17.04M$-16.37M$-10.73M$-2.32M$4.24M$3.70M$-10.90M$-11.42M$-5.84M$7.44M$19.26M$22.78M$19.24M$-696000.00$4.53M$10.06M$20.05M$26.23M
Operating margin-121.4%-112.0%-109.3%-29.6%-4.1%5.8%5.2%-15.2%-16.3%-7.5%7.2%16.8%17.9%14.4%-0.7%3.5%7.1%12.5%14.5%
EBITDA$-20.33M$-14.67M$-15.52M$-9.38M$2.72M$7.18M$8.09M$-8.31M$-7.10M$-1.98M$11.25M$23.46M$27.79M$25.41M$4.01M$10.81M$21.53M$27.80M$39.25M
EBITDA margin-151.3%-96.4%-103.6%-25.9%4.9%9.9%11.5%-11.6%-10.1%-2.6%10.9%20.5%21.9%19.1%3.9%8.4%15.1%17.3%21.7%
EBIT$-22.45M$-17.04M$-17.99M$-12.16M$-142198.00$4.14M$5.09M$-11.10M$-10.33M$-5.34M$7.60M$19.90M$23.27M$20.17M$-1.60M$-1.34M$10.06M$13.99M$24.33M
Interest expense$442710.00$4.60M$4.04M$5.03M$3.79M$3.35M$3.15M$3.03M$934000.00$126000.00$82000.00$327126.00$293000.00$266000.00$283000.00$914000.00$1.30M$660000.00$864000.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-22.90M$-12.45M$-22.03M$-15.17M$-3.49M$260000.00$443000.00$-12.64M$-11.27M$-6.73M$6.90M$22.30M$22.25M$17.14M$-2.23M$-2.32M$8.28M$14.46M$20.20M
Net income growth (YoY)+45.6%-77.0%+31.1%+77.0%+107.4%+70.4%-2952.4%+10.8%+40.3%+202.5%+223.1%-0.2%-23.0%-113.0%-4.1%+456.9%+74.6%+39.7%
Profit margin-170.4%-81.8%-147.1%-41.8%-6.2%0.4%0.6%-17.6%-16.1%-8.7%6.7%19.5%17.5%12.9%-2.2%-1.8%5.8%9.0%11.2%

Frequently asked questions

What is Kamada's revenue?

Kamada's trailing twelve-month revenue is $181.68M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is KMDA?

In its most recent fiscal year, KMDA ran a gross margin of 42.34%, an operating margin of 14.54%, and a net margin of 11.19%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does KMDA generate?

KMDA produced $16.93M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is KMDA's balance sheet healthy?

KMDA holds $75.48M in cash and equivalents against — in long-term debt, on $269.13M of shareholder equity. That debt is best read against the cash flow the business throws off each year.